Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Maher Haddad
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox
(
-11
properties)
Infobox
Patent primary examiner of
US Patent 7087724 Carrier molecules
US Patent 7115713 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
US Patent 7119169 RelA-associated inhibitor, process for producing the same and utilization thereof
US Patent 7960126 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
US Patent 7972846 Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders
US Patent 7988973 Activin-ActRII antagonists and uses for increasing red blood cell levels
US Patent 7989171 Anti-human tenascin monoclonal antibody
US Patent 7993849 Human TIMP-1 antibodies
US Patent 7998738 Integrin-binding antibodies
US Patent 8007809 Activin-actrii antagonists and uses for increasing red blood cell levels
US Patent 8012696 Monoclonal antibody capable of binding integrin alpha 10 beta 1
Edits on 13 Dec, 2021
Golden AI
edited on 13 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8012696 Monoclonal antibody capable of binding integrin alpha 10 beta 1
Edits on 8 Dec, 2021
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8007809 Activin-actrii antagonists and uses for increasing red blood cell levels
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7998738 Integrin-binding antibodies
Edits on 8 Dec, 2021
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7993849 Human TIMP-1 antibodies
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7989171 Anti-human tenascin monoclonal antibody
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7988973 Activin-ActRII antagonists and uses for increasing red blood cell levels
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7972846 Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7960126 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
Edits on 17 Nov, 2021
Golden AI
edited on 17 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7119169 RelA-associated inhibitor, process for producing the same and utilization thereof
Golden AI
edited on 17 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7115713 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
Edits on 16 Nov, 2021
Golden AI
edited on 16 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7087724 Carrier molecules
"Created via: Entity Importer"
Golden AI
created this topic on 16 Nov, 2021
Edits made to:
Infobox
(
+2
properties)
Maher Haddad
Infobox
Is a
Person
Current Employer
United States Patent and Trademark Office
Find more people like Maher Haddad
Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE